Main Results Of The First-In Human Single Ascending Dose Phase I Study Of Isth0036, An Antisense Oligonucleotide Selectively Targeting Transforming Growth Factor Beta 2 (Tgf-Beta 2) In Glaucoma Filtration Surgery
Investigative Ophthalmology & Visual Science（2017）
Key words
glaucoma filtration surgery,growth factor beta
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined